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Gene transfer of Smad7 using electroporation of adenovirus Tubulointerstitial fibrosis is the final common pathway
prevents renal fibrosis in post-obstructed kidney. in the process of human progressive renal diseases. Per-
Background. Unilateral ureteral obstruction (UUO) leads sistent inflammation and repeated injury to the renal in-
to interstitial fibrosis of the obstructed kidney, and TGF- is
terstitium progressively destroy an extensive amount ofconsidered to play an important role in this fibrotic process.
kidney tissue and, as a consequence, usually produce aSmad7 has been recently identified as an antagonist of TGF-
considerable decrease in renal function [1–3]. The mech-signaling. To investigate whether this novel molecule can be
exploited for therapy of renal fibrosis, we determined the effect anisms underlying the progression of renal disease to
of exogenous Smad7, introduced by a recombinant adenovirus end-stage renal failure are not well understood. The pro-
vector combined with in vivo electroporation (EP), on UUO- cess of tubulointerstitial fibrosis involves many changesinduced renal fibrosis in rats.
in the renal expression of a number of genes associatedMethods. A model of UUO was made in SD rats by ligating
with cell proliferation, differentiation, and survival. Thesetheir left ureters. The next day, the rats were divided into four
groups and adenovirus was injected into the extended pelvic include marked stimulation of transforming growth fac-
space (two groups received AdCMV-LacZ and two groups tor- (TGF-) [4–6]. Thus, the development of a gene
received AdCMV-Smad7). Then, EP was performed in one transfer technique to regulate TGF- signaling in renal
group of AdCMV-LacZ-injected rats and one group of AdCMV- tubules and interstitial fibroblasts is an appropriate strat-Smad7-injected rats. The renal tissues were obtained 3, 5, 10,
egy for the treatment of tubulointerstitial fibrosis. A geneand 14 days after the UUO operation. We detected the effi-
transfer technique of this type also may help to clarifyciency of transgene by immunoblots of renal cortical and med-
ullary tissues and immunohistochemical studies for Smad7 and our understanding of the pathophysiological role of in-
FLAG (the FLAG gene was introduced in the AdCMV-Smad7 terstitial fibroblasts and to further investigate the process
as a marker). The renal fibrosis was monitored by histological of renal fibrosis.
scoring of Masson stainings.
In the early 1990s Klahr and colleagues pioneered aResults. In immunoblotting, both Smad7 and FLAG were
model of chronic unilateral ureteral obstruction (UUO),clearly detected in the renal medullary tissue of the rats given
a well characterized experimental model of renal injuryAdCMV-Smad7 with EP. In contrast, immunoblots of renal
cortical tissue did not demonstrate positive bands. In immuno- leading to tubulointerstitial fibrosis [7]. Chronic UUO
histological study, Smad7 was stained in the renal medulla results in the stimulation of the renin-angiotensin system
in the rats given AdCMV-Smad7 with EP. In the rats given and TGF- system [5, 6]. TGF- is up-regulated and plays
AdCMV-Smad7 without EP, only a weak signal was detected
an important role in the pathogenesis of renal interstitialin renal medullary tissue. The rats given AdCMV-Smad7 with
fibrosis in the UUO model [8]. The prolonged overpro-EP demonstrated significantly more suppression of renal fibro-
duction of TGF- induced by chronic ureteral obstruc-sis than rats treated with AdCMV-LacZ. The rats treated with
AdCMV-Smad7 without EP did not demonstrate significant tion is believed to lead to an accumulation of pathologi-
suppression of renal fibrosis. cal amounts of extracellular matrix in the renal tissue,
Conclusion. These data indicate that gene transfer of Smad7 ultimately resulting in functional deterioration [5, 7].prevents UUO-induced renal fibrosis, suggesting that Smad7
Recent studies have revealed mechanisms of intracel-may be applicable for the treatment of renal fibrosis. In vivo
lular transduction of TGF- (Fig. 1). TGF- transmits sig-electroporation of adenovirus may be a powerful tool for gene
delivery in renal tissue. nals from the membrane to nucleus using Smad proteins
[9, 10]. The activated TGF- receptors induce phosphor-
ylation of Smad2 and Smad3. Smad2 and Smad3 make
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by perfusing the kidney with the adenovirus [17]. In
addition, Zhu et al reported that there was no significant
transduction of adenovirus to the tubular cells, while
there was transduction to the interstitial vasculature [18].
Further studies will be needed to clarify the reasons for
these discrepant results in spite of the use of similar adeno-
viral vectors. In an investigation of the ex vivo gene trans-
fer into the isolated human kidney under conditions of
organ preservation using an adenovirus polylysine DNA
complex and pulsatile perfusion for two hours at 4C,
Zeigler et al found that the gene expression was local-
ized to a significant fraction in the proximal tubular epi-
thelial cells. Adenoviruses can transduce many terminally
differentiated cell types, including hepatocytes, skeletal
Fig. 1. Inhibitory role of Smad7 in TGF- signaling TGF- transmits muscle, endothelium, glia, neuron, pulmonary epithelium,signals from the membrane to nucleus using Smad proteins. The acti-
and synovial cells [19, 20]. For efficient transduction withvated TGF- receptors induce phosphorylation of Smad2 and Smad3.
Hetero-oligomeric complexes with Smad2/3 and Smad4 translocate to adenovirus, prolonged exposure of the tissue to adenovi-
the nucleus and regulate transcriptional responses. Smad7 acts as an rus is believed to be necessary [21]. For this reason,intracellular antagonist of TGF- signaling. Smad7 blocks the activated
injection of adenovirus into closed pelvic space of theTGF- receptors and interferes with the activation of Smad2 and Smad3.
UUO model may be an efficient condition for gene trans-
fer by adenovirus to renal tissue.
Gene transfer by in vivo electroporationresponses [9–12]. Recently, Smad7 has been reported
as an intracellular antagonist of TGF- signaling [13]. Electroporation has been widely used to introduce
Smad7 associates with and blocks the activated type I DNA into various types of cells in vitro. Recently, gene
TGF- receptor and interferes with the activation of transfer by electroporation in vivo (DNA injection fol-
Smad2 and Smad3 by preventing their receptor interac- lowed by application of electric fields) has been effective
tion and phosphorylation. These basic reports indicate for introducing DNA into mouse muscle [22] and rat
the therapeutic potential of Smad7 to prevent TGF-– liver [23]. Reports have demonstrated that in vivo elec-
mediated renal tubulointerstitial fibrosis via the block- troporation provides an efficient approach for muscle-
ade of TGF- signaling. and liver-targeted gene transfer compared to DNA injec-
To test the hypothesis, we determined the effect of tion without electroporation. Thus, we hypothesized that
exogenous Smad7 introduced by a recombinant human adenovirus-mediated gene transfer with in vivo electro-
type 5 adenovirus vector [14, 15] into the kidney in a poration would increase the efficiency of gene transfer
UUO rat model that required TGF- for the develop- by adenovirus to renal tissue.
ment of the tissue fibrosis [5, 6]. To investigate whether
Expression of Smad7 transgene in rat cortex andthis novel molecule can be exploited for therapy of renal
medulla of UUO modelfibrosis, we determined the effect of exogenous Smad7,
introduced by a recombinant adenovirus vector com- Male Sprague-Dawley rats (200–250 g of body weight
bined with in vivo electroporation (EP), on UUO- at the start of the experiments) were used in this study.
induced renal fibrosis in rats. Under light anesthesia with pentobarbital, complete
ureteral obstruction of the left kidney was produced by
ligating the ureter with 4-0 silk suture through a smallMETHODS
abdominal incision. The next day, the rats were di-
Gene transfer into renal tubules using adenovirus vided into four groups, and adenovirus was injected into
Several recent reports have been published on in vivo the extended pelvic space (two groups injected with
adenoviral gene transfer to the kidney. When the adeno- AdCMV-LacZ and two groups injected with AdCMV-
virus was simply injected into the renal artery, very weak Smad7). Then, EP (electroporation) was performed in
and patchy expression of the reporter gene was observed one AdCMV-LacZ-injected group and one AdCMV-
in the cortex [16]. The expression lasted for two weeks. Smad7-injected group. Electric pulses were generated
The same group also reported that the retrograde trans- with an Electro Square Porator (T820:BTX, San Diego,
fection from the renal pelvis caused expression of the CA). Pulses were administered to the kidney by a pair
reporter gene in the papilla and medulla. The expression of electrode disks (1 cm diameter) rigged on the tips of
lasted for one to two weeks. In contrast, Heikkila et al tweezers (Pinsettes-Type electrode 449-10PRG: Meiwa
Syoji, Tokyo, Japan) [23]. Ten electric pulses were admin-demonstrated that no tubular expression was observed
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Fig. 2. Expression of Smad7 transgene in rat renal cortex and medulla
UUO-treatment. Complete ureteral obstruction of the left kidney was
produced by ligating the ureter. The next day, the rats were divided
into four groups and adenovirus was injected into the extended pelvic
space (two groups received AdCMV-LacZ and two groups received
AdCMV-Smad7). Then, EP (electroporation) was performed in one
group of AdCMV-LacZ-injected rats and one group of AdCMV-Smad7- Fig. 3. Quantitative analysis of expression of Smad7 transgene in the
injected rats. Expression of Smad7 transgene in rat cortex (C) and medulla renal tissue of rats after UUO-treatment. The rats were divided into
(M) was detected by Western blotting using anti-FLAG antibody. four groups and adenovirus was injected into the extended pelvic space
(two groups received AdCMV-LacZ and two groups received AdCMV-
Smad7). Then, EP (electroporation) was performed in one group of
AdCMV-LacZ-injected rats and one group of AdCMV-Smad7-injected
istered at a rate of one pulse per second. Pulses were de- rats. Expression of Smad7 transgene was detected by Western blotting
using anti-FLAG antibody, and the intensity of the bands detected atlivered to each rat kidney placed between the electrode
days 3 was measured using NIH Image software. Data are mean disks separated by a distance of approximately 2 mm. SEM (N  4).
Electric pulses were 50 ms in duration at voltages of 100 V.
The renal tissues were obtained 3, 5, 10, and 14 days
after the UUO operation. We detected the efficiency meruli, and interstitial apace by Masson’s trichrome
of gene transfer by immunoblots of renal cortical and method. Renal tissues obtained from control or UUO
medullary tissues and immunohistochemical studies for rats were fixed in formalin overnight and then dehy-
Smad7 and FLAG (the FLAG gene was introduced in drated and embedded in paraffin. Thin sections were
the AdCMV-Smad7 as a marker). Immunoblot analyses examined by Masson’s trichrome staining as described
were performed in the cortex and medulla from the previously [24]. The fibrotic areas stained in light blue
UUO model rats (day 3) using anti-FLAG antibody. in the interstitium and tubular basement membrane were
We first compared adenovirus vectors AdCMV-Smad7 picked up on the digital images using a computer-aided
for their ability to express the transgenes in rat renal tis- manipulator (microscope, Leitz, DM IRB; softare, Quan-
sue. Western blotting using anti-FLAG antibody at day 3 timet 500, Leica, Tokyo, Japan), and the percentage
showed significant expression of exogenous Smad7 pro- of the fibrotic area relative to the whole area of the field
was calculated (percent fibrotic area) as described pre-tein in the medulla of UUO model rats given AdCMV-
viously [24].Smad7 plus EP (Fig. 2). In the group given AdCMV-
In histological examination of renal specimens, renalSmad7 without EP, the expression of transgene was
tubulointerstitial fibrosis was most evident in rat kidneydetectable by anti-FLAG Western blotting, but the in-
14 days after UUO-treatment. Treatment of rats withtensity of expression was lower than that of the AdCMV-
AdCMV-LacZ plus EP did not significantly affect theSmad7-plus-EP group at day 3 (Fig. 2). Immunohisto-
renal interstitial fibrotic changes induced by UUO treat-chemical staining using the anti-FLAG antibody and
ment. However, when rats were treated with AdCMV-anti-Smad7 antibody was also performed at day 3. The
Smad7 plus EP following UUO-treatment, fibrotic le-data obtained showed that exogenous Smad7 protein
sions were significantly reduced. Quantitative evalua-was expressed in renal tubular cells in the outer and
tion of the histological findings by scoring of fibroticinner medulla and interstitial fibroblast-like cells. No
lesions showed significant suppression of UUO-inducedstaining was observed in the specimens using control
fibrotic changes in the rats treated with AdCMV-Smad7rabbit antiserum. The quantitative analysis of transgene
(AdCMV-LacZ treatment  97  12% mean  SD;expression using densitometry is shown in Figure 3.
AdCMV-Smad7 treatment  52  11% mean  SD;
N  4, P  0.01).Suppression of renal fibrosis by exogenous
expression of Smad7
DISCUSSIONThe area of interstitium with fibrotic lesions was deter-
mined on the sections was determined by staining the In this study, we showed that transient gene transfer
and expression of Smad7, introduced by recombinantcollagen fibers in the tubular basement membrane, glo-
Terada et al: Gene transfer of SMAD7 in UUO model S-97
human type 5 adenovirus vector with in vivo electropora- using adenovirus. However, the exact mechanisms of in
vivo electroporation of adenovirus are not known. Fortion into the kidney, prevented UUO-induced renal tu-
bulointerstitial fibrosis in rats. We propose that the ex- now we should examine the effects of different electrode
voltages, pulse lengths, numbers of pulses, and DNApression of exogenous Smad7 might exert its antifibrotic
effect in rat kidney via the blockade TGF- signal trans- concentrations in our experimental model. The use of
Smad7 as an antifibrotic agent should be investigated asduction.
Although the precise mechanisms of the tubulointer- a potentially novel therapy for several kinds of renal
fibrotic disorders. However, in its present form, the aden-stitial fibrosis process remain unclear, recent studies have
demonstrated the importance of TGF- and the renin- ovector-mediated, in vivo electroporation approach has
potential problems for application to human renal disor-angiotensin system in the pathogenesis of renal tubulo-
interstitial fibrosis [5, 25]. Shimizu et al. reported that ders. In light of this problem, we clearly need to develop
strategies to promote the efficiency gene transfer beforeTGF- mRNA increased from day 3 after the UUO
procedure, and expression of type IV collagen and type initiating such an investigation. Furthermore, unfavor-
able effects that might develop as a result of the long-I collagen mRNA also increased in this model [5]. Pro-
longed overexpression of TGF- is one of the major term elimination of the TGF- action, such as malig-
nancy, must be investigated carefully.pathological factors responsible for the fibrotic changes
in renal tissue in the UUO model. In conclusion, our data indicate that the gene transfer
of Smad7 prevents UUO-induced renal fibrosis, sug-Smad7 has recently been identified [12, 13], and the
role of Smad7 as an intracellular inhibitor of TGF- gesting that Smad7 may be applicable in the treatment
of renal fibrosis. In vivo electroporation of adenovirussignaling is well accepted [26]. However, the in vivo bio-
logical activity of the inhibitory Smad7 has not yet been may be a powerful tool for gene delivery in renal tissue.
defined. Our findings suggested that Smad7 functioned
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